{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:18:14Z","timestamp":1790389094291,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>\n                    Among soft tissue tumors, MUC4 is expressed in low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, and is regarded as a specific and sensitive marker for these malignant entities. These tumors are driven by oncogenic fusions involving\n                    <jats:italic toggle=\"yes\">FUS<\/jats:italic>\n                    or\n                    <jats:italic toggle=\"yes\">EWSR1<\/jats:italic>\n                    as a 5\u2019 partner and\n                    <jats:italic toggle=\"yes\">CREB3L1<\/jats:italic>\n                    or\n                    <jats:italic toggle=\"yes\">CREB3L2<\/jats:italic>\n                    as a 3\u2019 partner. In this study, we describe the clinicopathologic and molecular features of a distinctive fibroblastic soft tissue neoplasm characterized by consistent co-expression of MUC4 and beta-catenin, and frequent underlying\n                    <jats:italic toggle=\"yes\">APC<\/jats:italic>\n                    inactivation without evidence of\n                    <jats:italic toggle=\"yes\">EWSR1<\/jats:italic>\n                    or\n                    <jats:italic toggle=\"yes\">FUS<\/jats:italic>\n                    rearrangements. Fifteen hyalinized spindle cell neoplasms with MUC4 and aberrant nuclear beta-catenin co-expression were identified from our institutional archives. The cohort comprised 15 adult patients (6 female, 9 male) with a median age of 40 years (range: 20 to 61). Tumors arose in the extremities (n=9), trunk (n=5), and retroperitoneum (n=1), with a median size of 8.5\u00a0cm (range: 2.8 to 18.0\u00a0cm). The tumors consisted of a hypocellular proliferation of spindled-to-stellate fibroblastic cells in a variably hyalinized collagenous stroma. No atypia, fascicular growth, or myxoid stroma was present. Targeted DNA sequencing was successfully performed on 8 tumors. In addition, 8 tumors underwent FISH testing to assess for\n                    <jats:italic toggle=\"yes\">FUS<\/jats:italic>\n                    and\/or\n                    <jats:italic toggle=\"yes\">EWSR1<\/jats:italic>\n                    rearrangement. In the majority of tumors, DNA sequencing demonstrated\n                    <jats:italic toggle=\"yes\">APC<\/jats:italic>\n                    inactivation (7\/8; 88%). In 6 of these cases, 2 concurrent deleterious\n                    <jats:italic toggle=\"yes\">APC<\/jats:italic>\n                    alterations were present, indicative of biallelic inactivation. No rearrangements involving\n                    <jats:italic toggle=\"yes\">FUS<\/jats:italic>\n                    or\n                    <jats:italic toggle=\"yes\">EWSR1<\/jats:italic>\n                    were identified by NGS and\/or FISH. Clinical follow-up data were available for 4 patients, with no local recurrences or metastases reported, including 1 patient followed for 8 years. No patients had a known history of familial adenomatous polyposis. We describe a novel fibroblastic soft tissue neoplasm characterized by co-expression of MUC4 and beta-catenin and frequent underlying\n                    <jats:italic toggle=\"yes\">APC<\/jats:italic>\n                    inactivation, for which we propose the name \u201cMUC4-positive fibroblastoma.\u201d\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002441","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T06:00:39Z","timestamp":1750658439000},"page":"1125-1132","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["MUC4-positive Fibroblastoma"],"prefix":"10.1097","volume":"49","author":[{"given":"Federico","family":"Repetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Odintsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette M.","family":"Sholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L.","family":"Hornick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5807-7831","authenticated-orcid":false,"given":"William J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"R1-20251022","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/PAS.0b013e318210c268","article-title":"MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma","volume":"35","author":"Doyle","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R2-20251022","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/labinvest.3700230","article-title":"Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma and cloning of a novel FUS\/CREB3L1 fusion gene","volume":"85","author":"Mertens","year":"2005","journal-title":"Lab Invest"},{"key":"R3-20251022","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1097\/PAS.0b013e3182562bf8","article-title":"MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement","volume":"36","author":"Doyle","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R4-20251022","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.pas.0000157938.95785.da","article-title":"Nuclear \u03b2-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions","volume":"29","author":"Bhattacharya","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R5-20251022","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2559.2007.02794.x","article-title":"Immunohistochemistry for \u03b2-catenin in the differential diagnosis of spindle-cell lesions: analysis of a series and review of the literature","volume":"51","author":"Carlson","year":"2007","journal-title":"Histopathology"},{"key":"R6-20251022","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/01.pas.0000213348.65014.0a","article-title":"Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas","volume":"31","author":"Coffin","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R7-20251022","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00000478-200105000-00012","article-title":"Gardner-associated fibromas in young patients: a distinct fibrous lesion that identifies unsuspected Gardner syndrome and risk for fibromatosis","volume":"25","author":"Wehrli","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R8-20251022","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/ajcp\/aqv094","article-title":"Morphologic spectrum of desmoid-type fibromatosis","volume":"145","author":"Zreik","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"R9-20251022","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5858\/arpa.2016-0527-OA","article-title":"Validation of OncoPanel: a targeted next-generation sequencing assay for the detection of somatic variants in cancer","volume":"141","author":"Garcia","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"R10-20251022","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1101\/gr.221028.117","article-title":"SvABA: genome-wide detection of structural variants and indels by local assembly","volume":"4","author":"Wala","year":"2018","journal-title":"Genome Res"},{"key":"R11-20251022","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1128\/MCB.22.4.1172-1183.2002","article-title":"Wnt\/\u03b2-catenin\/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway","volume":"22","author":"Jho","year":"2002","journal-title":"Mol Cell Biol"},{"key":"R12-20251022","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10689-014-9775-7","article-title":"The roles of AXIN2 in tumorigenesis and epigenetic regulation","volume":"14","author":"Li","year":"2015","journal-title":"Fam Cancer"},{"key":"R13-20251022","doi-asserted-by":"crossref","first-page":"109469","DOI":"10.1016\/j.cellsig.2019.109469","article-title":"HOX family transcription factors: related signaling pathways and post-translational modifications in cancer","volume":"66","author":"Yu","year":"2020","journal-title":"Cell Signal"},{"key":"R14-20251022","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11684-024-1119-x","article-title":"HOXB13 in cancer development: molecular mechanisms and clinical implications","volume":"3","author":"Zhang","year":"2025","journal-title":"Front Med"},{"key":"R15-20251022","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/ajcp\/88.5.615","article-title":"Low-grade fibromyxoid sarcoma: report of two metastasizing neoplasms having a deceptively benign appearance","volume":"88","author":"Evans","year":"1987","journal-title":"Am J Clin Pathol"},{"key":"R16-20251022","first-page":"781","article-title":"Collagenous fibroma (desmoplastic fibroblastoma): report of seven cases","volume":"9","author":"Nielsen","year":"1996","journal-title":"Mod Pathol"},{"key":"R17-20251022","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cancergen.2011.10.003","article-title":"Translocation t(2;11) is characteristic of collagenous fibroma (desmoplastic fibroblastoma)","volume":"204","author":"Nishio","year":"2011","journal-title":"Cancer Genet"},{"key":"R18-20251022","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/path.6038","article-title":"Recurrent FOSL1 rearrangements in desmoplastic fibroblastoma","volume":"259","author":"De Noon","year":"2023","journal-title":"J Pathol"},{"key":"R19-20251022","doi-asserted-by":"crossref","first-page":"102314","DOI":"10.1016\/j.labinv.2024.102314","article-title":"Novel low-grade fibroblastic neoplasm with co-expression of MUC4 and \u03b2-catenin: clinicopathologic and molecular characterization of eight cases","volume":"105","author":"Tavberidze","year":"2025","journal-title":"Lab Invest"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002441","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T13:00:25Z","timestamp":1761138025000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002441"}},"subtitle":["A Distinctive Hyalinized Spindle Cell Neoplasm With Aberrant Nuclear Beta-catenin Expression and Frequent Biallelic Inactivation of APC"],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002441","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]}}}